Skip to main content

Table 1 Clinical characteristics of ICU patients with CKD (N = 925)

From: The association between blood albumin level and cardiovascular complications and mortality risk in ICU patients with CKD

Variables

Without CV complications (N = 455)

With CV complications (N = 470)

P value

Age (year)

69.19 (59.20–79.24)

76.55 (67.74–82.83)

 < 0.001

Gender (male), n (%)

303 (66.59%)

290 (61.70%)

0.121

Insurance types

   

Insurance-Government, n (%)

6 (1.32%)

4 (0.85%)

 < 0.001

Insurance-Medicaid, n (%)

37 (8.13%)

25 (5.32%)

Insurance-Medicare, n (%)

297 (65.27%)

369 (78.51%)

Insurance-Private, n (%)

112 (24.62%)

72 (15.32%)

Insurance-Self Pay, n (%)

3 (0.66%)

0 (0.00%)

Ethnicity

   

Ethnicity-White, n (%)

329 (72.31%)

354 (75.32%)

0.601

Ethnicity-Black, n (%)

55 (12.09%)

50 (10.64%)

Ethnicity-Asian, n (%)

10 (2.20%)

13 (2.77%)

Ethnicity-Other, n (%)

61 (13.41%)

53 (11.28%)

Concomitant diseases

   

Hypertension, n (%)

36 (7.91%)

35 (7.45%)

0.790

Diabetes, n (%)

27 (5.93%)

42 (8.94%)

0.082

Malignant tumor, n (%)

53 (11.65%)

23 (4.89%)

 < 0.001

CV complications

   

HF, n (%)

427 (90.85%)

MI, n (%)

39 (8.30%)

Stroke, n (%)

40 (8.51%)

Medication during ICU

   

Albumin, n (%)

98 (21.54%)

85 (18.09%)

0.187

βRB, n (%)

259 (56.92%)

319 (67.87%)

 < 0.001

Statins, n (%)

92 (20.22%)

143 (30.43%)

 < 0.001

Heparin, n (%)

265 (58.24%)

265 (56.38%)

0.568

Death during ICU, n (%)

88 (19.34%)

109 (23.19%)

0.153

1-year mortality after ICU, n (%)

180 (39.56%)

226 (48.09%)

0.009

  1. -1st: the first laboratory value in ICU; -max: the maximum laboratory value in ICU; -min: the minimum laboratory value in ICU
  2. CV, cardiovascular; ICU, intensive care unit; CKD, chronic kidney disease; HF, heart failure; MI, myocardial infarction; βRB, β Receptor blocker